Limited mouth opening after primary treatments for head and neck cancer

Source: Stanford University Author: Weber, S Dommerich, HW Pau, and B Kramp OBJECTIVES: Patients after surgery and radiation/chemoradiation for treatment of head and neck cancer often suffer from oral complications. These problems may be caused by surgery and radiation. Patients complain, for example, of swallowing problems and limited mouth opening (trismus). METHODS: The maximal interincisal mouth opening (MIO) was measured in patients treated with surgery and radiation/chemoradiation for head and neck cancer at the Department of Otorhinolaryngology at the University of Rostock. These patients also completed a 20-item questionnaire concerning nutritional, sensual, and speech disorders and pain. RESULTS: One hundred one patients (16 female and 85 male) returned the questionnaire and were included in the study. About 50% of the patients had a limited mouth opening (<36 mm); patients with oropharyngeal cancer had a significant higher risk for trismus (p = .024) than patients with other head and neck cancers, especially compared to patients with laryngeal cancer (p = .013). The questionnaire showed that especially patients with oral cancer report about problems with opening the mouth (73%), eating (65%), drinking (73%), xerostomia (92%), speech disorders (68%), and voice (62%). Patients with laryngeal cancer only reported about problems with xerostomia (62%), speech (83%), and voice (90%), similar to patients with pharyngeal cancer. CONCLUSIONS: About half of the patients who underwent primary treatment for oral and oropharyngeal cancer developed trismus and reported about problems with opening the mouth, eating, drinking, dry mouth, voice, and speech. Trismus has a negative impact on quality [...]

2010-04-19T22:25:48-07:00April, 2010|Oral Cancer News|

With cancer, let’s face it: words are inadequate

Source: nytimes.com Author: Dana Jennings We’re all familiar with sentences like this one: Mr. Smith died yesterday after a long battle with cancer. We think we know what it means, but we read it and hear it so often that it carries little weight, bears no meaning. It’s one of the clichés of cancer. It is easy shorthand. But it says more about the writer or speaker than it does about the deceased. We like to say that people “fight” cancer because we wrestle fearfully with the notion of ever having the disease. We have turned cancer into one of our modern devils. But after staggering through prostate cancer and its treatment — surgery, radiation and hormone therapy — the words “fight” and “battle” make me cringe and bristle. I sometimes think of cancer as a long and difficult journey, a quest out of Tolkien, or a dark waltz — but never a battle. How can it be a battle when we patients are the actual battleground? We are caught in the middle, between our doctors and their potential tools of healing and the cell-devouring horde. We become a wasteland, at once infested by the black dust of cancer and damaged by the “friendly fire” of treatment. And ordinary language falls far short of explaining that keen sense of oblivion. As a patient, it’s hard to articulate how being seriously ill feels. In a profound way, we are boiled down to our essential animal selves. We crave survival. We long [...]

George vs. The Dragon

Source: ESPN.com Author: Rick Reilly DAY 17: Tuesday, March 9, 7:30 a.m. -- Denver Nuggets coach George Karl pops in his mouthpiece and puts on his helmet and braces himself for a brutal 15 minutes, but this isn't football. This is cancer radiation. We're at Denver's Swedish Medical Center. The helmet is actually a white, hard-mesh mask that fits to every contour of Karl's big bucket head. It has red crosses all over it, like a hockey goalie's. He lays his 283 pounds on the table and the technicians clamp the mask on hard. How Karl breathes I'll never know. They secure his limbs and ask him to hold a blue plastic donut so no part of him moves. He looks like Hannibal Lecter about to get fried. "It makes you a little claustrophobic," the 58-year-old coach tries to say through the mask. "But what are you gonna do? Leave?" Coaching the wildly talented but wildly uneven Nuggets is hard enough, let alone doing it with throat and neck cancer, but that's what Karl is trying to do. Everybody tells him it's not possible, and today, maybe he's starting to believe them. With only three of his torturous six weeks of treatment done, and the inside of his mouth looking like he just took 100 bites out of a lava-hot pizza slice, and his head throbbing and his eyes hollow, Karl looks like a guy who should be on a stretcher, not an NBA bench. "George, this is only going [...]

2010-03-18T09:51:54-07:00March, 2010|Oral Cancer News|

Lymphedema common in head and neck cancer

Source: www.medpagetoday.com Author: Charles Bankhead, Staff Writer, MedPage Today Treatment of head and neck cancer causes potentially severe lymphedema, which responds to complete decongestive therapy in most cases, a retrospective chart review showed. The most severe lymphedema occurred in patients treated with surgery and radiation therapy, followed by definitive surgery alone. Complete decongestive therapy led to clinical improvement in a majority of the patients, including 83% of those treated with surgery alone. "Lymphedema is vastly under-recognized and under-reported in patients with head and neck cancer," Jan S. Lewin, PhD, of M.D. Anderson Cancer Center in Houston, said in an interview at the Multidisciplinary Head and Neck Cancer Symposium (MHNCS). "The lymphedema can be just as severe as what's seen after treatment of breast and other types of cancer. Lymphedema in patients with head and neck cancer can be terribly disfiguring and cause severe functional problems." "Complete decongestive therapy leads to clinically significant improvement in most patients, whether it's performed in a clinic or at home," she added. Available evidence suggests that fewer than half of patients with head and neck cancer develop lymphedema after treatment. However, cosmetic and functional sequelae can be severe, including problems with speaking, eating, airway obstruction, and drooling, as well as self-image. As compared with lymphedema in other cancers, a paucity of information exists about the presentation and treatment of the condition in patients with head and neck cancer, said Lewin. In an effort to add to the information base, she and her colleagues retrospectively reviewed [...]

Cancer survivor tells his experience with smokeless tobacco

Source: Lifestyles Author: Nicole Printz Just like the trucks on every corner in Abilene, rings on back jean pockets are a common sight. Gruen Von Behrens, who visited Abilene High School on Wednesday, knows all about smokeless tobacco. He began with snuff at 13 years old. He asked the packed high school auditorium if the students knew someone who smoked cigarettes. A sea of hands rose at the question, with almost the same number rising for his next question – did they know someone who used smokeless tobacco? “I think about half our school smokes or uses smokeless tobacco,” Dynae Whiteley, a junior, said. “I mean, not to get anyone in trouble or anything.” “I have friends and relatives that use tobacco,” said senior Matt Bowers. “I think smokeless tobacco is safer because the use of cigarettes affects more people through second-hand smoke. Smokeless tobacco only affects that person.” Collin Sexton, a sophomore, also thought smokeless tobacco would be safer than smoking. Dynae Whiteley and Paige Piper, both juniors, thought all tobacco was “equally bad.” According to the Communities That Care 2009 survey, 23.1 percent of Dickinson County students sixth through 12th grade have used smokeless tobacco, and 27.4 percent had smoked a cigarette. Almost half of all seniors in Dickinson County had smoked a cigarette at least once. This statistics are almost double the state average. Von Behrens, one of the eight members of the National Spit Tobacco Education Program’s speakers bureau, continued his life story. He said “not [...]

2010-03-08T10:41:41-07:00March, 2010|Oral Cancer News|

Viagra, Cialis do more than arouse

Source: www.kptv.com Author: staff More than 30 million men take them for erectile dysfunction, but the drugs marketed to treat male impotence are now being investigated for the treatment of more than a dozen diseases and health problems. Researchers say ED drugs like Viagra could turn out to be as versatile as aspirin. They're the images of happy couples that helped make erectile dysfunction drugs a $3 billion business. But now doctors say those little pills may also save lives. Brian Kumnick is fighting throat cancer. He's been through months of radiation and surgery. “The radiation, it's barbaric,” Kumnick told Ivnahoe. “It's really barbaric, and I've lost my taste buds, for example. I can't taste anything. Water tastes like acid going down." He's part of a clinical trial to see if the ED drug Cialis can cure head and neck cancers. "It'd be really nice to just take a pill that has a pleasant side effect,” Kumnick said. In preliminary studies, doctors at Johns Hopkins say Cialis energized patients' immune systems so their bodies could battle the cancer cells. Next, they'll test to see if the drug also shrinks tumors. "When we looked at the blood of head and neck cancer patients, we could get their immune response to rev up to near normal levels, whereas they were suppressed maybe 75 percent, sometimes even 80 percent,” Joseph Califano, M.D., professor in the Department of Otolaryngology-Head and Neck Surgery at Johns Hopkins Hospital in Baltimore, Md., told Ivanhoe. From fighting cancer, [...]

New uses for erectile disfunction drugs

Source: abclocal.go.com/wjrt Author: Leslie Toldo Could Viagra be the next cancer cure? HealthFirst reporter Leslie Toldo shows us why doctors think some impotence drugs may be as versatile as aspirin. E-D, or erectile dysfunction drugs, are being explored as treatments for more than a dozen diseases and health problems. They're the images of happy couples that helped make erectile dysfunction drugs a $3 billion business. But now doctors say those little pills may also save lives. "I did ask them what on earth they were talking about," said cancer patient Brian Kumnick. Kumnick is fighting throat cancer. He's been through months of radiation and surgery. "Well, the radiation, it's barbaric. It's really barbaric, and I've lost my taste buds, for example. I can't taste anything. Water tastes like acid going down." He's part of a clinical trial to see if the E-D drug Cialis can cure head and neck cancers. "It'd be really nice to just take a pill that has a pleasant side effect," Kumnick said. In preliminary studies, doctors at Johns Hopkins say Cialis energized patients' immune systems so their bodies could battle the cancer cells. Next, they'll test to see if the drug also shrinks tumors. Dr. Joseph Califano is a professor in the Department of Otolaryngology-Head and Neck Surgery at Johns Hopkins Hospital. "When we looked at the blood of head and neck cancer patients, we could get their immune response to rev up to near normal levels, whereas they were suppressed maybe 75 percent, sometimes [...]

2010-02-18T22:26:38-07:00February, 2010|Oral Cancer News|

Nuggets’ coach again fighting cancer- this time of the throat

Source: ESPN Author: Ric Bucher Denver Nuggets coach George Karl informed his team Tuesday afternoon that he is in another fight for his life with cancer. Karl, who had been cancer-free since prostate surgery in July 2005, discovered a worrisome lump on his neck about six weeks ago. A biopsy determined that it was "very treatable and curable" form of neck and throat cancer, Karl said, but it will still require an intense program of radiation and chemotherapy that will probably force him to miss some regular-season games. "Cancer is a vicious opponent," he said. "Even the ones that are treatable, you never get a 100-percent guaranteed contract." Treatment will consist of 35 sessions over the next six weeks, for what the Nuggets Web site called squamous cell head/neck cancer. The sessions are expected to leave his throat extremely raw, requiring him to be fed through his stomach in the final weeks. "Keeping up your nutrition is a big part of the challenge," he said. While the condition is treatable, his doctor, Jacques Saari, said Karl faces a taxing treatment regimen. He said the chemotherapy was intended to make the cancerous cells in Karl's body more susceptible to the effects of radiation. Then, he said, "The idea is to really hit it hard with radiation therapy." But the radiation, to be administered continuously for five days a week for the next six weeks, will take a physical toll on Karl, especially during the latter portion of treatment, Saari said. "Coach [...]

2010-02-17T15:41:54-07:00February, 2010|Oral Cancer News|

Determination of malnourishment in the head and neck cancer patient: assessment tools and nutrition education of radiation oncologists

Source: Support Care Cancer, January 14, 2010 Authors: PV Decicco, SM Wunderlich, and JS Emmolo Purpose: The purpose of this study is to evaluate current assessment practices of malnourishment by radiation oncologists among the head and neck cancer patient population. Methods: A cross-sectional descriptive study was conducted. A 14-question survey was mailed to 333 radiation oncologists self-identified as "interested in the treatment of head and neck cancer." Results: About 87% of radiation oncologists indicated that they used bodyweight as the sole determinant of malnourishment in head and neck cancer patients at initial consultation. Radiation oncologists with 0 to 10 years experience were found to have a higher level of formal nutrition education than those with 11 to 20 years (p = 0.0052). A significant difference was found between radiation oncologists with formal nutrition education vs. those without, in answering whether nutrition interventions play a significant role in the prognosis of such cancer patients (p = 0.0013). In addition, a significant difference was noted in methods used to determine proper caloric intake when the oncologists were stratified by their beliefs about nutrition being a significant variable affecting the prognosis of head and neck cancer patients (p = 0.0024). Conclusion: Assessment or screening for malnourishment in the head and neck cancer patient should be a routine part of the initial consultation. Radiation oncologists and their medical team, including nutritionists, should use an appropriate nutrition screening and assessment tool in addition to the body weight as an indicator of malnourishment. Nutrition education provided [...]

2010-02-13T18:57:06-07:00February, 2010|Oral Cancer News|

F.D.A. to increase medical radiation oversight

Source: nytimes.com Authors: Walt Bogdanich & Rebecca R. Ruiz The federal Food and Drug Administration said Tuesday that it would take steps to more stringently regulate three of the most potent forms of medical radiation, including increasingly popular CT scans, some of which deliver the radiation equivalent of 400 chest X-rays. With the announcement, the F.D.A. puts its regulatory muscle behind a growing movement to make life-saving medical radiation — both diagnostic and therapeutic — safer. Last week, the leading radiation oncology association called for enhanced safety measures. And a Congressional committee was set to hear testimony Wednesday on the weak oversight of medical radiation, but the hearing was canceled because of bad weather. The F.D.A. has for weeks been investigating why more than 300 patients in four hospitals were overradiated by powerful CT scans used to detect strokes. The overdoses were first discovered last year at Cedars-Sinai Medical Center in Los Angeles, where patients received up to eight times as much radiation as intended. The errors occurred over 18 months and were detected only after patients lost their hair. In making the announcement, the F.D.A. said it hoped to reduce unnecessary radiation exposure from three medical imaging procedures: CT scans, which provide three-dimensional images; nuclear medicine studies, in which patients are given a radioactive substance and doctors watch it move through the body; and fluoroscopies, in which a radiation-emitting device provides a continuous internal image on a monitor. “These types of imaging exams expose patients to ionizing radiation, a [...]

2010-02-09T21:34:45-07:00February, 2010|Oral Cancer News|
Go to Top